0001792612-19-000002.txt : 20191031 0001792612-19-000002.hdr.sgml : 20191031 20191031132055 ACCESSION NUMBER: 0001792612-19-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191031 DATE AS OF CHANGE: 20191031 EFFECTIVENESS DATE: 20191031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Avenzoar Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001792612 IRS NUMBER: 475352251 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-352278 FILM NUMBER: 191182957 BUSINESS ADDRESS: STREET 1: 662 ENCINITAS BLVD., SUITE 248 CITY: ENCINITAS STATE: CA ZIP: 92024 BUSINESS PHONE: (310) 502-0770 MAIL ADDRESS: STREET 1: 662 ENCINITAS BLVD., SUITE 248 CITY: ENCINITAS STATE: CA ZIP: 92024 D 1 primary_doc.xml X0708 D LIVE 0001792612 Avenzoar Pharmaceuticals, Inc. 662 ENCINITAS BLVD., SUITE 248 ENCINITAS CA CALIFORNIA 92024 858-356-9563 CALIFORNIA None None Corporation true 2015 Terrance Bruggeman c/o Avenzoar Pharmaceuticals, Inc. 662 Encinitas Blvd., Suite 248 Encinitas CA CALIFORNIA 92024 Executive Officer Director William Reavey c/o Avenzoar Pharmaceuticals, Inc. 662 Encinitas Blvd., Suite 248 Encinitas CA CALIFORNIA 92024 Executive Officer David Kramer c/o Avenzoar Pharmaceuticals, Inc. 662 Encinitas Blvd., Suite 248 Encinitas CA CALIFORNIA 92024 Executive Officer Mouad Edderkaoui c/o Avenzoar Pharmaceuticals, Inc. 662 Encinitas Blvd., Suite 248 Encinitas CA CALIFORNIA 92024 Director Pharmaceuticals Decline to Disclose 06b false 2019-10-17 false true true false 0 918172 525144 393028 false 4 0 0 0 false Avenzoar Pharmaceuticals, Inc. /s/ Terrance Bruggeman Terrance Bruggeman Chief Executive Officer 2019-10-31